{
  "company": {
    "name": "Eureka Therapeutics",
    "website": "https://eurekatherapeutics.com/",
    "record": "https://startuphistory.org/c/eurekatherapeutics.com"
  },
  "status": null,
  "history_since": "2017-08-25T01:03:04.000Z",
  "baseline": {
    "snapshot_id": "4cecbd6ca4029b5c7db37944b16bbe00cf4933f6dee066b94d8081dc476189ac",
    "observed_at": "2017-08-25T01:03:04.000Z",
    "headline": "Eureka Therapeutics | Therapeutics",
    "description": "Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pi",
    "evidence": "https://web.archive.org/web/20170825010304/https://www.eurekatherapeutics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 2,
  "last_checked": "2026-11-06T16:57:59.023Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2017-08-25T01:03:04.000Z",
      "variants": [
        {
          "headline": "Eureka Therapeutics | Therapeutics",
          "subhead": "Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pi",
          "observed_at": "2017-08-25T01:03:04.000Z",
          "evidence": "https://web.archive.org/web/20170825010304/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Eureka Therapeutics | Therapeutics",
      "subhead": "Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pi",
      "from": "2017-08-25T01:03:04.000Z",
      "to": "2017-08-25T01:03:04.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20170825010304/https://www.eurekatherapeutics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2017-08-25T01:03:04.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T16:57:59.023Z",
      "variants": [
        {
          "headline": "Harnessing the evolutionary power of the immune system with the goal of curing cancer",
          "subhead": "Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.",
          "observed_at": "2018-08-19T16:09:31.000Z",
          "evidence": "https://web.archive.org/web/20180819160931/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Harnessing the evolutionary power of the immune system with the goal of curing cancer",
          "subhead": "Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.",
          "observed_at": "2019-07-19T01:31:54.000Z",
          "evidence": "https://web.archive.org/web/20190719013154/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Harnessing the evolutionary power of the immune system with the goal of curing cancer",
          "subhead": "Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.",
          "observed_at": "2021-02-28T18:10:48.000Z",
          "evidence": "https://web.archive.org/web/20210228181048/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Harnessing the evolutionary power of the immune system with the goal of curing cancer",
          "subhead": "Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.",
          "observed_at": "2022-02-16T07:40:17.000Z",
          "evidence": "https://web.archive.org/web/20220216074017/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2022-07-05T20:09:17.000Z",
          "evidence": "https://web.archive.org/web/20220705200917/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2023-08-19T04:13:16.000Z",
          "evidence": "https://web.archive.org/web/20230819041316/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2024-07-12T18:22:38.000Z",
          "evidence": "https://web.archive.org/web/20240712182238/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2025-04-29T06:28:32.000Z",
          "evidence": "https://web.archive.org/web/20250429062832/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2026-04-10T16:13:48.000Z",
          "evidence": "https://web.archive.org/web/20260410161348/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2026-04-10T16:13:48.000Z",
          "evidence": "https://web.archive.org/web/20260410161348/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2026-05-30T00:51:19.000Z",
          "evidence": "https://web.archive.org/web/20260530005119/https://www.eurekatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2026-11-05T14:04:24.291Z",
          "evidence": "https://www.eurekatherapeutics.com/",
          "evidence_kind": "live_capture"
        },
        {
          "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
          "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
          "observed_at": "2026-11-06T16:57:59.023Z",
          "evidence": "https://www.eurekatherapeutics.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "HARNESSING THE EVOLUTIONARY POWER OF",
      "subhead": "Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c",
      "from": "2018-08-19T16:09:31.000Z",
      "to": "2026-11-06T16:57:59.023Z",
      "captures": 13,
      "evidence": "https://www.eurekatherapeutics.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2018-08-19T16:09:31.000Z",
          "to": "2026-11-06T16:57:59.023Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Eureka Therapeutics” company record, https://startuphistory.org/c/eurekatherapeutics.com"
}